Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide is a chemical compound with the molecular formula C12H13NO4S. It is a white to off-white solid and is known for its presence as an impurity in the pharmaceuticals Piroxicam and Meloxicam.

24683-26-9 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • High quality 4-Hydroxy-2-Methyl-2H-1,2-Benzothiazine-3-Carboxylic Acid Ethylester-1,1-Dioxide supplier in China

    Cas No: 24683-26-9

  • No Data

  • No Data

  • Metric Ton/Day

  • Simagchem Corporation
  • Contact Supplier
  • 4-Hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylic acid ethyl ester 1,1-dioxide

    Cas No: 24683-26-9

  • USD $ 1.2-5.0 / Kiloliter

  • 5 Kiloliter

  • 3000 Metric Ton/Month

  • Chemwill Asia Co., Ltd.
  • Contact Supplier
  • 24683-26-9 Structure
  • Basic information

    1. Product Name: Ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
    2. Synonyms: (4-Hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylic acid ethyl)1,1-dioxide;Ethyl 4-Hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-Dioxide (Piroxicam Impurity K);2-benzothiazine-3-carboxylic acid ethyl ester-1;2-Methyl-4-hydroxy-2H-1;Meloxicam Related Compound A (25 mg) (ethyl-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate- 1,1-dioxide);MeloxicaM IMpurity A(EP) (USP RC A);Ethyl 4-hydroxy-2-methyl-1,1-dioxo-2H-1,2-benzothiazine-3-carboxylate 97%;ETHYL 4-HYDROXY-2-METHYL-1,1-DIOXO-2H-1,2-BENZOTHIAZINE-3-CARBOXYLATE
    3. CAS NO:24683-26-9
    4. Molecular Formula: C12H13NO5S
    5. Molecular Weight: 283.3
    6. EINECS: 246-403-7
    7. Product Categories: Intermediates & Fine Chemicals;Pharmaceuticals;Sulfur & Selenium Compounds;Organic acids;API intermediates;(intermediate of piroxicam);Aromatics Compounds;Aromatics;Heterocycles;Building Blocks;Heterocyclic Building Blocks;Thiazines
    8. Mol File: 24683-26-9.mol
  • Chemical Properties

    1. Melting Point: 140-144 °C(lit.)
    2. Boiling Point: 424.1°Cat760mmHg
    3. Flash Point: 210.3°C
    4. Appearance: /
    5. Density: 1.444g/cm3
    6. Vapor Pressure: 5.97E-08mmHg at 25°C
    7. Refractive Index: 1.61
    8. Storage Temp.: -20°C Freezer
    9. Solubility: N/A
    10. PKA: 4.50±1.00(Predicted)
    11. CAS DataBase Reference: Ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide(CAS DataBase Reference)
    12. NIST Chemistry Reference: Ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide(24683-26-9)
    13. EPA Substance Registry System: Ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide(24683-26-9)
  • Safety Data

    1. Hazard Codes: T
    2. Statements: 23
    3. Safety Statements: 45
    4. RIDADR: UN 2811 6.1/PG 2
    5. WGK Germany: 2
    6. RTECS: DL0710425
    7. HazardClass: N/A
    8. PackingGroup: N/A
    9. Hazardous Substances Data: 24683-26-9(Hazardous Substances Data)

24683-26-9 Usage

Uses

Used in Pharmaceutical Industry:
Ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide is used as an impurity in the manufacturing process of certain pharmaceutical drugs, specifically Piroxicam (impurity K) and Meloxicam (M216100). Its presence, although as an impurity, is significant for the development and formulation of these medications.
Used in Quality Control and Analysis:
In the pharmaceutical industry, Ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide is also used for quality control and analysis purposes. Its identification and quantification in drug products help ensure the safety, efficacy, and purity of the final medication, contributing to the overall quality assurance process.
Used in Research and Development:
This chemical compound may also be utilized in research and development for the pharmaceutical industry. It can serve as a starting material or a reference compound for the synthesis of new drug candidates or for studying the chemical properties and interactions of related compounds.

Check Digit Verification of cas no

The CAS Registry Mumber 24683-26-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,4,6,8 and 3 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 24683-26:
(7*2)+(6*4)+(5*6)+(4*8)+(3*3)+(2*2)+(1*6)=119
119 % 10 = 9
So 24683-26-9 is a valid CAS Registry Number.
InChI:InChI=1/C12H13NO5S/c1-3-18-12(15)10-11(14)8-6-4-5-7-9(8)19(16,17)13(10)2/h4-7,15H,3H2,1-2H3/b12-10+

24683-26-9 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma-Aldrich

  • (Y0001035)  MeloxicamimpurityA  European Pharmacopoeia (EP) Reference Standard

  • 24683-26-9

  • Y0001035

  • 2,231.19CNY

  • Detail
  • Aldrich

  • (552429)  Ethyl4-hydroxy-2-methyl-1,1-dioxo-2H-1,2-benzothiazine-3-carboxylate  97%

  • 24683-26-9

  • 552429-25G

  • 2,574.00CNY

  • Detail
  • USP

  • (1379412)  MeloxicamRelatedCompoundA  United States Pharmacopeia (USP) Reference Standard

  • 24683-26-9

  • 1379412-25MG

  • 14,578.20CNY

  • Detail

24683-26-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name Ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

1.2 Other means of identification

Product number -
Other names 2-METHYL-4-HYDROXY-2H-1,2-BENZOTHIAZINE-1,1-DIOXIDE-3-CARBOXYLIC ACID ETHYL ESTER

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:24683-26-9 SDS

24683-26-9Synthetic route

4-hydroxy-2H-1,2-benzothiazine-3-carboxylic acid ethyl ester 1,1-dioxide
24683-21-4

4-hydroxy-2H-1,2-benzothiazine-3-carboxylic acid ethyl ester 1,1-dioxide

dimethyl sulfate
77-78-1

dimethyl sulfate

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

Conditions
ConditionsYield
With hydrogenchloride In water at 10℃; for 18h; pH=7.5;78.9%
2-(Ethoxycarbonylmethyl-methyl-sulfamoyl)-benzoic acid ethyl ester
113412-08-1

2-(Ethoxycarbonylmethyl-methyl-sulfamoyl)-benzoic acid ethyl ester

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

Conditions
ConditionsYield
With lithium diisopropyl amide In tetrahydrofuran at -78℃; for 5.5h;76%
4-hydroxy-2H-1,2-benzothiazine-3-carboxylic acid ethyl ester 1,1-dioxide
24683-21-4

4-hydroxy-2H-1,2-benzothiazine-3-carboxylic acid ethyl ester 1,1-dioxide

methyl iodide
74-88-4

methyl iodide

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

Conditions
ConditionsYield
With sodium hydroxide In ethanol at 20℃; for 18h;72%
With sodium methylate In N,N-dimethyl-formamide
With sodium hydroxide In ethanol; water at 20℃; for 24h;
ethyl 2-(1,1-dioxido-3-oxobenzo[d]isothiazol-2(3H)-yl) acetate
24683-20-3

ethyl 2-(1,1-dioxido-3-oxobenzo[d]isothiazol-2(3H)-yl) acetate

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 68 percent / EtONa / ethanol / 1 h / 55 °C
2: 72 percent / aq. NaOH / ethanol / 18 h / 20 °C
View Scheme
Multi-step reaction with 2 steps
1: 1) NaOEt / 1) room temperature, 7-10 min.; 2) room temperature, 2 h
2: 76 percent / lithium diisopropylamide / tetrahydrofuran / 5.5 h / -78 °C
View Scheme
Multi-step reaction with 2 steps
1: NaOEt / ethanol
2: NaOMe / dimethylformamide
View Scheme
Multi-step reaction with 2 steps
1: sodium methylate / dimethyl sulfoxide / 1 h / 30 °C
2: sodium hydroxide / water; ethanol / 24 h / 20 °C
View Scheme
Multi-step reaction with 2 steps
1: hydrogenchloride; sodium / ethanol / 0.5 h / 70 °C / pH 8 - 9
2: hydrogenchloride / water / 18 h / 10 °C / pH 7.5
View Scheme
saccharin sodium salt
128-44-9

saccharin sodium salt

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 72 percent / dimethylformamide / 3 h / 100 °C
2: 68 percent / EtONa / ethanol / 1 h / 55 °C
3: 72 percent / aq. NaOH / ethanol / 18 h / 20 °C
View Scheme
Multi-step reaction with 3 steps
1: N,N-dimethyl-formamide / 3 h / 75 °C
2: hydrogenchloride; sodium / ethanol / 0.5 h / 70 °C / pH 8 - 9
3: hydrogenchloride / water / 18 h / 10 °C / pH 7.5
View Scheme
4-hydroxy-2H-1,2-benzothiazine-3-carboxylic acid ethyl ester 1,1-dioxide
24683-21-4

4-hydroxy-2H-1,2-benzothiazine-3-carboxylic acid ethyl ester 1,1-dioxide

methyl halide

methyl halide

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

Conditions
ConditionsYield
Stage #1: 4-hydroxy-2H-1,2-benzothiazine-3-carboxylic acid ethyl ester 1,1-dioxide With sodium hydroxide In ethanol; water
Stage #2: methyl halide In ethanol; water at 20℃; for 12h;
saccharin
81-07-2

saccharin

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: sodium hydride / N,N-dimethyl-formamide / 3.5 h / 80 °C / Cooling with ice
2: sodium methylate / dimethyl sulfoxide / 1 h / 30 °C
3: sodium hydroxide / water; ethanol / 24 h / 20 °C
View Scheme
5-methyl-2-thiazol-2-amine
7305-71-7

5-methyl-2-thiazol-2-amine

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

meloxicam
71125-38-7

meloxicam

Conditions
ConditionsYield
In o-xylene for 24h; Product distribution / selectivity; Heating / reflux;95%
In xylene at 139 - 140℃; for 32 - 37h; Product distribution / selectivity; Heating / reflux; Molecular sieve;92.48%
trifluoromethylsulfonic anhydride
358-23-6

trifluoromethylsulfonic anhydride

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

C13H12F3NO7S2

C13H12F3NO7S2

Conditions
ConditionsYield
With pyridine In dichloromethane at 0℃; for 24.1667h;92%
With pyridine In dichloromethane
5-methyl-2-thiazol-2-amine
7305-71-7

5-methyl-2-thiazol-2-amine

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

1,2-dichloro-benzene
95-50-1

1,2-dichloro-benzene

meloxicam
71125-38-7

meloxicam

Conditions
ConditionsYield
With 1,2-dichloro-ethane76%
ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carbohydrazide 1,1-dioxide
105743-62-2

4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carbohydrazide 1,1-dioxide

Conditions
ConditionsYield
With hydrazine hydrate In ethanol for 2h; Reflux;68%
4-chloro-aniline
106-47-8

4-chloro-aniline

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

N-(4'-chlorophenyl)-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
35511-63-8

N-(4'-chlorophenyl)-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 140 - 150℃; for 12h;64%
3-trifluoromethylaniline
98-16-8

3-trifluoromethylaniline

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

4-hydroxy-2-methyl-N-[3-(trifluoromethyl)phenyl]-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
35511-66-1

4-hydroxy-2-methyl-N-[3-(trifluoromethyl)phenyl]-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 140 - 150℃; for 12h;60%
ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

2-amino-6-chloropyrazine
33332-28-4

2-amino-6-chloropyrazine

N-(6-chloro-pyrazin-2-yl)-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide

N-(6-chloro-pyrazin-2-yl)-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide

Conditions
ConditionsYield
60%
ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

aniline
62-53-3

aniline

4-hydroxy-2-methyl-N-phenyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
34258-79-2

4-hydroxy-2-methyl-N-phenyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 140 - 150℃; for 12h;57%
4-trifluoromethylphenylamine
455-14-1

4-trifluoromethylphenylamine

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

4-hydroxy-2-methyl-N-[4-(trifluoromethyl)phenyl]-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
35510-91-9

4-hydroxy-2-methyl-N-[4-(trifluoromethyl)phenyl]-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 140 - 150℃; for 12h;56%
5-amino-3,4-dimethylisoxazol
19947-75-2

5-amino-3,4-dimethylisoxazol

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

4-Hydroxy-2-methyl-1,1-dioxo-1,2-dihydro-1λ6-benzo[e][1,2]thiazine-3-carboxylic acid (3,4-dimethyl-isoxazol-5-yl)-amide
55620-59-2

4-Hydroxy-2-methyl-1,1-dioxo-1,2-dihydro-1λ6-benzo[e][1,2]thiazine-3-carboxylic acid (3,4-dimethyl-isoxazol-5-yl)-amide

Conditions
ConditionsYield
In xylene for 24h; Heating;55%
5-methylisoxazol-3-ylamine
1072-67-9

5-methylisoxazol-3-ylamine

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

isoxicam
34552-84-6

isoxicam

Conditions
ConditionsYield
In xylene for 24h; Heating;49%
5-amino-3-methylisoxazole
14678-02-5

5-amino-3-methylisoxazole

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

4-Hydroxy-2-methyl-1,1-dioxo-1,2-dihydro-1λ6-benzo[e][1,2]thiazine-3-carboxylic acid (3-methyl-isoxazol-5-yl)-amide
55620-58-1

4-Hydroxy-2-methyl-1,1-dioxo-1,2-dihydro-1λ6-benzo[e][1,2]thiazine-3-carboxylic acid (3-methyl-isoxazol-5-yl)-amide

Conditions
ConditionsYield
In xylene for 24h; Heating;43%
ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

5-aminoisoxazole
14678-05-8

5-aminoisoxazole

4-Hydroxy-2-methyl-1,1-dioxo-1,2-dihydro-1λ6-benzo[e][1,2]thiazine-3-carboxylic acid isoxazol-5-ylamide
79672-22-3

4-Hydroxy-2-methyl-1,1-dioxo-1,2-dihydro-1λ6-benzo[e][1,2]thiazine-3-carboxylic acid isoxazol-5-ylamide

Conditions
ConditionsYield
In xylene for 24h; Heating;35%
3-aminoisoxazole
1750-42-1

3-aminoisoxazole

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

4-Hydroxy-2-methyl-1,1-dioxo-1,2-dihydro-1λ6-benzo[e][1,2]thiazine-3-carboxylic acid isoxazol-3-ylamide
38938-72-6

4-Hydroxy-2-methyl-1,1-dioxo-1,2-dihydro-1λ6-benzo[e][1,2]thiazine-3-carboxylic acid isoxazol-3-ylamide

Conditions
ConditionsYield
In xylene for 24h; Heating;32%
2-amino-4,5-dimethyloxazole
45529-92-8

2-amino-4,5-dimethyloxazole

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

2-methyl-1,1,4-trioxo-1,2,3,4-tetrahydro-1λ6-benzo[e][1,2]thiazine-3-carboxylic acid 4,5-dimethyl-oxazol-2-ylamide
40713-57-3

2-methyl-1,1,4-trioxo-1,2,3,4-tetrahydro-1λ6-benzo[e][1,2]thiazine-3-carboxylic acid 4,5-dimethyl-oxazol-2-ylamide

Conditions
ConditionsYield
In xylene for 24h; Heating;
3-aminobenzisothiazole
23031-78-9

3-aminobenzisothiazole

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

2-methyl-1,1,4-trioxo-1,2,3,4-tetrahydro-1λ6-benzo[e][1,2]thiazine-3-carboxylic acid benzo[d]isothiazol-3-ylamide
67345-05-5

2-methyl-1,1,4-trioxo-1,2,3,4-tetrahydro-1λ6-benzo[e][1,2]thiazine-3-carboxylic acid benzo[d]isothiazol-3-ylamide

Conditions
ConditionsYield
With toluene-4-sulfonic acid In N,N-dimethyl acetamide at 120 - 140℃;
2-amino-4-methyl-thiazole-5-carbonitrile
67322-84-3

2-amino-4-methyl-thiazole-5-carbonitrile

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

2-methyl-1,1,4-trioxo-1,2,3,4-tetrahydro-1λ6-benzo[e][1,2]thiazine-3-carboxylic acid 5-cyano-4-methyl-thiazol-2-ylamide
67322-76-3

2-methyl-1,1,4-trioxo-1,2,3,4-tetrahydro-1λ6-benzo[e][1,2]thiazine-3-carboxylic acid 5-cyano-4-methyl-thiazol-2-ylamide

Conditions
ConditionsYield
In xylene Heating;
5-amino-2,3-dimethylindole
16712-58-6

5-amino-2,3-dimethylindole

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

2-methyl-1,1,4-trioxo-1,2,3,4-tetrahydro-1λ6-benzo[e][1,2]thiazine-3-carboxylic acid 2,3-dimethyl-indol-5-ylamide
40713-58-4

2-methyl-1,1,4-trioxo-1,2,3,4-tetrahydro-1λ6-benzo[e][1,2]thiazine-3-carboxylic acid 2,3-dimethyl-indol-5-ylamide

Conditions
ConditionsYield
In xylene for 24h; Heating;
4-phenyl-oxazol-2-ylamine
33119-65-2

4-phenyl-oxazol-2-ylamine

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

2-methyl-1,1,4-trioxo-1,2,3,4-tetrahydro-1λ6-benzo[e][1,2]thiazine-3-carboxylic acid 4-phenyl-oxazol-2-ylamide
40713-56-2

2-methyl-1,1,4-trioxo-1,2,3,4-tetrahydro-1λ6-benzo[e][1,2]thiazine-3-carboxylic acid 4-phenyl-oxazol-2-ylamide

Conditions
ConditionsYield
In xylene for 24h; Heating;
6-methoxybenzothiazol-2-ylamine
1747-60-0

6-methoxybenzothiazol-2-ylamine

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

2-methyl-1,1,4-trioxo-1,2,3,4-tetrahydro-1λ6-benzo[e][1,2]thiazine-3-carboxylic acid 6-methoxy-benzothiazol-2-ylamide
67322-75-2

2-methyl-1,1,4-trioxo-1,2,3,4-tetrahydro-1λ6-benzo[e][1,2]thiazine-3-carboxylic acid 6-methoxy-benzothiazol-2-ylamide

Conditions
ConditionsYield
With toluene-4-sulfonic acid In N,N-dimethyl acetamide at 120 - 140℃;
2-(4-aminophenyl)-6-methyl-1,3-benzothiazole
92-36-4

2-(4-aminophenyl)-6-methyl-1,3-benzothiazole

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

2-methyl-1,1,4-trioxo-1,2,3,4-tetrahydro-1λ6-benzo[e][1,2]thiazine-3-carboxylic acid 4-(6-methyl-benzothiazol-2-yl)-anilide
40713-51-7

2-methyl-1,1,4-trioxo-1,2,3,4-tetrahydro-1λ6-benzo[e][1,2]thiazine-3-carboxylic acid 4-(6-methyl-benzothiazol-2-yl)-anilide

Conditions
ConditionsYield
In xylene for 24h; Heating;
1H-indazol-5-ylamine
19335-11-6

1H-indazol-5-ylamine

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

2-methyl-1,1,4-trioxo-1,2,3,4-tetrahydro-1λ6-benzo[e][1,2]thiazine-3-carboxylic acid 1(2)H-indazol-5-ylamide
40713-55-1

2-methyl-1,1,4-trioxo-1,2,3,4-tetrahydro-1λ6-benzo[e][1,2]thiazine-3-carboxylic acid 1(2)H-indazol-5-ylamide

Conditions
ConditionsYield
In xylene for 24h; Heating;
1-amino-5,6,7,8-tetrahydronaphthalene
2217-41-6

1-amino-5,6,7,8-tetrahydronaphthalene

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

2-methyl-1,1,4-trioxo-1,2,3,4-tetrahydro-1λ6-benzo[e][1,2]thiazine-3-carboxylic acid 5,6,7,8-tetrahydro-naphthalen-4-ylamide
67322-72-9

2-methyl-1,1,4-trioxo-1,2,3,4-tetrahydro-1λ6-benzo[e][1,2]thiazine-3-carboxylic acid 5,6,7,8-tetrahydro-naphthalen-4-ylamide

Conditions
ConditionsYield
With toluene-4-sulfonic acid In N,N-dimethyl acetamide at 120 - 140℃;
chloridazon
1698-60-8

chloridazon

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

2-methyl-1,1,4-trioxo-1,2,3,4-tetrahydro-1λ6-benzo[e][1,2]thiazine-3-carboxylic acid 5-chloro-6-oxo-1-phenyl-1,6-dihydro-pyridazin-4-ylamide
67322-81-0

2-methyl-1,1,4-trioxo-1,2,3,4-tetrahydro-1λ6-benzo[e][1,2]thiazine-3-carboxylic acid 5-chloro-6-oxo-1-phenyl-1,6-dihydro-pyridazin-4-ylamide

Conditions
ConditionsYield
With toluene-4-sulfonic acid In N,N-dimethyl acetamide at 120 - 140℃;
meta-aminobenzoic acid
99-05-8

meta-aminobenzoic acid

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

3-(2-methyl-1,1,4-trioxo-1,2,3,4-tetrahydro-1λ6-benzo[e][1,2]thiazine-3-carbonylamino)-benzoic acid
67322-68-3

3-(2-methyl-1,1,4-trioxo-1,2,3,4-tetrahydro-1λ6-benzo[e][1,2]thiazine-3-carbonylamino)-benzoic acid

Conditions
ConditionsYield
With toluene-4-sulfonic acid In N,N-dimethyl acetamide at 120 - 140℃;
anthranilic acid
118-92-3

anthranilic acid

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

2-(2-methyl-1,1,4-trioxo-1,2,3,4-tetrahydro-1λ6-benzo[e][1,2]thiazine-3-carbonylamino)-benzoic acid
67322-67-2

2-(2-methyl-1,1,4-trioxo-1,2,3,4-tetrahydro-1λ6-benzo[e][1,2]thiazine-3-carbonylamino)-benzoic acid

Conditions
ConditionsYield
With toluene-4-sulfonic acid In N,N-dimethyl acetamide at 120 - 140℃;
ethanolamine
141-43-5

ethanolamine

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
24683-26-9

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

6-methyl-7,7-dioxo-3,4,6,7-tetrahydro-2H-7λ6-benzo[5,6][1,2]thiazino[3,4-f][1,4]oxazepin-5-one
67343-28-6

6-methyl-7,7-dioxo-3,4,6,7-tetrahydro-2H-7λ6-benzo[5,6][1,2]thiazino[3,4-f][1,4]oxazepin-5-one

Conditions
ConditionsYield
With toluene-4-sulfonic acid In xylene Heating;

24683-26-9Downstream Products

24683-26-9Relevant articles and documents

5-aminothiazole non-steroidal anti-inflammatory compound as well as preparation method and application thereof

-

Paragraph 0105; 0142-0143; 0145, (2020/09/20)

The invention discloses a 5-aminothiazole non-steroidal anti-inflammatory compound. The compound which is efficient, low in toxicity and small in side effect is prepared from an ester intermediate containing a thiazine ring and a 5-aminothiazole derivative through a transesterification reaction. The preparation method of the compound is simple, the compound has the active groups of the existing non-steroidal anti-inflammatory medicine; meanwhile, the special change of the nitrogen atom position is also designed; compared with the existing non-steroidal anti-inflammatory medicines, the compoundhas better anti-inflammatory and analgesic effects, particularly has good curative effects on arthritis, osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, soft tissue inflammation and thelike, has small toxic and side effects on human bodies, and has a very wide market prospect.

Piroxicam hapten and preparation method and application thereof

-

, (2019/10/23)

The invention aims to provide a piroxicam hapten and a synthesis method and application thereof, belonging to the field of drug safety detection. The preparation method comprises the following steps:1) mixing saccharin and ethyl bromoacetate for reacting to prepare an intermediate product 1; 2) mixing and extracting the intermediate product 1 with DMSO and MeONa to obtain an intermediate product2; 3) mixing the intermediate product 2 and CH3I for reacting to obtain an intermediate product 3; 4) mixing the intermediate product 3 and 6-aminonicotinic acid methyl ester for reacting to obtain anintermediate product 4; 5) after adding of the intermediate product 4 into a reagent for miscibility reaction, purifying to obtain the final product, namely the piroxicam hapten. Immunological detection method has the advantages of high sensitivity, strong specificity, simple sample pretreatment, short detection time, strong stability, no need of special equipment and reagents, intuitive judgmentof results and the like, thus being particularly suitable for rapid detection of illegal addition of piroxicam chemical drugs in vast basic inspection personnel and large quantities of anti-rheumatism Chinese patent medicines.

Discovery of cyclicsulfonamide derivatives as 11β-hydroxysteroid dehydrogenase 1 inhibitors

Kim, Se Hoan,Ramu, Ravirala,Kwon, Sung Wook,Lee, Su-Hee,Kim, Chi Hyun,Kang, Seung Kyu,Rhee, Sang Dal,Bae, Myung Ae,Ahn, Sung Hoon,Ha, Duck Chan,Cheon, Hyae Gyeong,Kim, Ki Young,Ahn, Jin Hee

supporting information; experimental part, p. 1065 - 1069 (2010/06/14)

A new series of cyclic sulfonamide derivatives was synthesized and evaluated for their ability to inhibit 11β-HSD1. Cyclic sulfonamides with phenylacetyl substituents at the 2-position showed nanomolar inhibitory activities. Among them, compound 4e exhibited a good in vitro inhibitory activity and selectivity toward human 11β-HSD2.

Site-specific acid-base properties of tenoxicam

Koczian, Kristof,Voelgyi, Gergely,Koekoesi, Jozsef,Noszal, Bela

, p. 1681 - 1690 (2008/02/13)

The Hammett approach, as a new deductive tool, was introduced to characterize the otherwise inaccessible minor protonation pathway of tenoxicam (1), the non-steroidal anti-inflammatory drug. A total of eight compounds, constituting a systematic series of side chain-substituted analogues of tenoxicam and piroxicam (2), were synthesized and studied in terms of acid-base properties and Hammett constants to identify the ideal replacement of the unprotonated pyridin-2-yl group, a key moiety in both molecules. Hammett constants of the phenyl substituents have been found to be in a linear correlation with the experimental log K values of the enolate sites, the basic moiety of the extended conjugated system in this family of piroxicam derivatives. Then, a similar correlation was observed for the analogous tenoxicam derivatives. After identifying the 2-aza Hammett constant of the pyridin-2-yl group and the corresponding log K value, the site-specific acid-base properties of tenoxicam could be quantitated. This novel method is assessed to be a fine-tuning tool to find the ideal substituent by using analogue-based deductive method to obtain site-specific constants of the minor protonation/deprotonation pathway in drugs and biomolecules. The tenoxicam microconstant values indicate that the enolate moiety is of extremely low basicity (reflected by the log kO = 3.70 and log kO N = 1.09 values), which can, however, be interpreted in terms of the peculiar ring system and the overwhelming electron-withdrawing effects of the adjacent heteroatoms. A diagram depicting the pH-dependent distribution of 1 microspecies is also presented.

CONDITIONS OF THE DIECKMANN CONDENSATION OF ALKYL 2-(N-METHYL-N-(ALKOXYCARBONYLMETHYL)SULFAMOYL-BENZOATES

Patek, Marcel,Hampl, Frantisek

, p. 3267 - 3277 (2007/10/02)

The Dieckmann condensation of alkyl 2-(N-methyl-N-(alkoxycarbonylmethyl)sulfamoyl)benzoates IIIa-IIIe with various bases affords alkyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxides IVa-IVe which are intermediates in the synthesis of antiinflammatory drug piroxicam.The yields of benzothiazines IVa-IVe depend mostly on the nature of a base, reaction temperature and solvent used for these condensations.Hitherto undescribed esters IIIb-IIIe were sythesized and their structures were confirmed by 1H and 13C NMR, and mass spectra.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 24683-26-9